Counselors in Lahaska, PA Accepting Medicare
2 Counselors found. Showing 1 - 2
 Dr. Romy Siess-tota, ED.D. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2772 Street Rd, Lahaska, PA 18931 Phone: 215-622-7151 |
Anne Marie Piotrowski, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 168 Peddlers Vlg Unit 10, Lahaska, PA 18931 Phone: 215-429-1473 |
News Archive
FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
Dermatologists caution that severe cases of psoriasis can be associated with other serious medical conditions
On the surface, the thick, red, scaly, itchy plaques of psoriasis - which have been shown to have a significant negative impact on a person's overall quality of life - may not appear to pose a serious health risk for patients. However, a growing body of research suggests that psoriasis patients are at an increased risk of developing serious medical conditions, including cardiovascular disease and diabetes, particularly when their psoriasis is severe.
Reviewing the latest methods for characterizing biomaterials
Biomaterials and medical devices must be rigorously tested in the laboratory before they may be implanted into test subjects. By ensuring that these test methods are both quick and efficient, an increased number of materials can be tested and working implants can be produced more rapidly. The development of such tests is therefore essential to biomedical advancement, and Characterization of biomaterials reviews the latest methods for defining properties and characterizing materials. Characterization of biomaterials discusses a wide array of techniques and various unique approaches to the problems faced in characterizing biomaterials, whilst also providing information on standards and methods for assessing the safety and biocompatibility of biomaterials.
Palliative care helps improve quality, cut end of life care costs
The Philadelphia Inquirer reports on palliative care and focuses on a fairly typical American hospital in Abington.
Morphotek commences MORAb-004 Phase II study in metastatic colorectal cancer
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy.
› Verified 5 days ago